Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
phenotype | 0.100 | None | 0.838 | 37 | 3 | 1997 | 2019 | ||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
phenotype | 0.100 | None | 0.867 | 30 | 1 | 1998 | 2020 | ||||||||
|
protein S | 0.467 | 0.846 | 4.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 23 | 2 | 1999 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.100 | None | 0.842 | 19 | 0 | 2004 | 2019 | ||||||||
|
cytochrome c oxidase subunit 8A | 0.400 | 0.846 | 0.12 |
|
phenotype | 0.100 | None | 0.947 | 19 | 0 | 1996 | 2018 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
phenotype | 0.100 | None | 0.938 | 16 | 2 | 1998 | 2019 | ||||||||
|
pyruvate carboxylase | 0.515 | 0.808 | 1.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 1991 | 2020 | ||||||||
|
thrombomodulin | 0.457 | 0.769 | 5.4E-02 |
|
phenotype | 0.100 | None | 0.923 | 13 | 6 | 1999 | 2018 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
phenotype | 0.100 | None | 1.000 | 12 | 2 | 1999 | 2019 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
phenotype | 0.100 | None | 1.000 | 12 | 1 | 2007 | 2019 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2017 | 2020 | ||||||||
|
tissue factor pathway inhibitor | 0.486 | 0.808 | 0.25 |
|
phenotype | 0.100 | None | 1.000 | 10 | 0 | 2002 | 2018 | ||||||||
|
ZFPM2 antisense RNA 1 | 0.736 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||||||
|
F11 antisense RNA 1 | 0.805 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 3 | 10 | 2011 | 2019 | |||||||||
|
phospholipase C gamma 2 | 0.588 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
basic leucine zipper nuclear factor 1 | 0.780 | 0.269 | 5.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2012 | ||||||||
|
FUN14 domain containing 2 | 0.760 | 0.385 | 6.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
coiled-coil domain containing 181 | 0.861 | 0.115 | 2.0E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2012 | ||||||||
|
complement component 4 binding protein alpha | 0.556 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
G protein-coupled receptor kinase 5 | 0.588 | 0.769 | 0.68 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
OSMR antisense RNA 1 (head to head) | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
nucleoporin 205 | 0.736 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
mature T cell proliferation 1 | 0.821 | 0.308 | 0.45 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |